Walleye Capital
TWST icon

Walleye Capital’s Twist Bioscience TWST Stock Holding History

Walleye Capital’s Portfolio TWST Stock Details TWST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-7,300
Closed -$232K – 5002
2025
Q4 		$232K Buy
+7,300
New +$228K ﹤0.01% 3468
2025
Q1 		– Sell
-4,600
Closed -$214K – 5155
2024
Q4 		$214K Buy
+4,600
New +$208K ﹤0.01% 3701
2024
Q3 		– Sell
-2,300
Closed -$113K – 5891
2024
Q2 		$113K Buy
+2,300
New +$93.8K ﹤0.01% 4656
2024
Q1 		– Sell
-5,600
Closed -$206K – 5906
2023
Q4 		$206K Sell
5,600
-6,900
-55% -$160K ﹤0.01% 3655
2023
Q3 		$253K Sell
12,500
-21,700
-63% -$477K ﹤0.01% 3374
2023
Q2 		$700K Buy
34,200
+25,400
+289% +$381K ﹤0.01% 2167
2023
Q1 		$133K Buy
+8,800
New +$194K ﹤0.01% 2768

Other funds holding TWST

Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $12.5B AUM 31.7% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Walleye Capital's TWST Position: Q3 2024 in Review

Walleye Capital sold out of Twist Bioscience (TWST) in Q3 2024, closing a stake of 1,013 shares — an estimated $49.9K sold.

Walleye Capital first reported a position in TWST in Q4 2020 and held it in 5 quarters. The position peaked at $1.24M in Q1 2023. 245 funds tracked by Wall St. Rank hold TWST as of Q3 2024.

  • Walleye Capital reported no remaining Twist Bioscience position as of Q3 2024 after selling out during the quarter.
  • Walleye Capital sold 1,013 Twist Bioscience shares in Q3 2024, an estimated $49.9K.
  • Walleye Capital first reported a position in Twist Bioscience in Q4 2020 and held it in 5 quarters.
  • Walleye Capital's Twist Bioscience position peaked at $1.24M in Q1 2023.
  • 245 funds tracked by Wall St. Rank held Twist Bioscience as of Q3 2024.

Based on Walleye Capital's 13F filing for Q3 2024, filed 14 Nov 2024.